1-4 of 4
Wenqun Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ALK Inhibitor Plus Vinblasitine for Refractory/Relapsed Pediatric ALK+ Anaplastic Large Cell Lymphoma: A Prospective, One-Arm, Open-Label Real-World Study

Wenqun Zhang, Shan Wang, Jing Yang, Bo Hu, Ying Liu, Ling Jing, Qing Zhu, Yang Liu, Qinlong Zheng, Chunju Zhou, Zifen Gao, Yonghong Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1406.
https://doi.org/10.1182/blood-2021-149402
Published: 2021
Journal Articles

Efficacy and Safety of Sequential Different B Cell Antigen-Targeted CAR T-Cell Therapy for Pediatric Refractory/Relapsed Burkitt Lymphoma with Secondary Central Nervous System Involvement

Ying Liu, Biping Deng, Bo Hu, Wenqun Zhang, Qing Zhu, Yang Liu, Shan Wang, Pei Zhang, Junhan Yang, Qinlong Zheng, Xinjian Yu, Zifen Gao, Chunju Zhou, Wei Han, Alex Hong Chang, Yonghong Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 257.
https://doi.org/10.1182/blood-2021-146302
Published: 2021
Journal Articles

Early response observed in pediatric patients with relapsed/refractory Burkitt lymphoma treated with chimeric antigen receptor T cells

Clinical Trials & Observations
Wenqun Zhang, Jing Yang, Chunju Zhou, Bo Hu, Ling Jin, Biping Deng, Yang Liu, Shan Wang, Alex H. Chang, Juan Du, Zifen Gao, Yonghong Zhang
Journal: Blood
Blood (2020) 135 (26): 2425–2427.
https://doi.org/10.1182/blood.2019002008
Published: 2020
Includes: Supplemental data
Journal Articles

Early Response Observed in Pediatric Patients with Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma Treated with Sequential Chimeric Antigen Receptor T Cells

Wenqun Zhang, MD, Bo Hu, MD, Ling Jing, MD, Jing Yang, MD, Shan Wang, MD, Yang Liu, MD, Juan Du, MD, Yaoliang Ren, MD, Yonghong Zhang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1945.
https://doi.org/10.1182/blood-2019-125753
Published: 2019